MétaCan
Menu
Back to cohort
Record W4396662878 · doi:10.1002/alz.13785

Generating real‐world evidence in Alzheimer's disease: Considerations for establishing a core dataset

2024· article· en· W4396662878 on OpenAlexafffund
James E. Galvin, Jeffrey L. Cummings, Mihaela Levitchi Benea, Carl de Moor, Ricardo Allegri, Alireza Atri, Howard Chertkow, Claire Paquet, Verna R. Porter, Craig Ritchie, Sietske A.M. Sikkes, Michael R. Smith, Christina M. Grassi, Ivana Rubino

Bibliographic record

VenueAlzheimer s & Dementia · 2024
Typearticle
Languageen
FieldMedicine
TopicDementia and Cognitive Impairment Research
Canadian institutionsBaycrest Hospital
FundersAllerganNational Institutes of HealthGenentechFleniGrifolsNational Institute of General Medical SciencesNovo NordiskH. Lundbeck A/SConsejo Nacional de Investigaciones Científicas y TécnicasZonMwEisaiUniversity of OxfordProthenaNational Institute on AgingAlzheimer's AssociationTauRx PharmaceuticalsBiogenAstraZenecaEli Lilly and CompanyCanadian Institutes of Health ResearchSunovionGilead SciencesFoundation for the National Institutes of Health
KeywordsObservational studyDementiaReal world dataReal world evidenceDiseaseMedicineCognitionQuality of life (healthcare)Data collectionData sciencePsychiatryComputer sciencePathologyInternal medicine

Abstract

fetched live from OpenAlex

Ongoing assessment of patients with Alzheimer's disease (AD) in postapproval studies is important for mapping disease progression and evaluating real-world treatment effectiveness and safety. However, interpreting outcomes in the real world is challenging owing to variation in data collected across centers and specialties and greater heterogeneity of patients compared with trial participants. Here, we share considerations for observational postapproval studies designed to collect harmonized longitudinal data from individuals with mild cognitive impairment or mild dementia stage of disease who receive therapies targeting the underlying pathological processes of AD in routine practice. This paper considers key study design parameters, including proposed aims and objectives, study populations, approaches to data collection, and measures of cognition, functional abilities, neuropsychiatric status, quality of life, health economics, safety, and drug utilization. Postapproval studies that capture these considerations will be important to provide standardized data on AD treatment effectiveness and safety in real-world settings.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.606
metaresearch head score (Gemma)0.798
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesMetaresearch
Consensus categoriesMetaresearch
DomainCandidate signal: Methods · Consensus signal: Methods
Study designCandidate signal: Theoretical or conceptual · Consensus signal: none
GenreCandidate signal: Methods · Consensus signal: Methods
Teacher disagreement score0.394
Threshold uncertainty score0.486

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.6060.798
Meta-epidemiology (narrow)0.0020.003
Meta-epidemiology (broad)0.0060.007
Bibliometrics0.0120.013
Science and technology studies0.0030.006
Scholarly communication0.0160.013
Open science0.0110.016
Research integrity0.0080.010
Insufficient payload (model declined to judge)0.0060.002

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.145
GPT teacher head0.400
Teacher spread0.255 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; the direct Gemma label and the distilled Codex classifier agree on what is shown here.

Study designTheoretical or conceptual
DomainMethods
GenreMethods

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations19
Published2024
Admission routes2
Has abstractyes

Explore more

Same venueAlzheimer s & DementiaSame topicDementia and Cognitive Impairment ResearchFrench-language works237,207